Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [517]
News [1431]
Articles [66]
Editorials [2]
Conferences [72]
elearning [5]
New antibody-drug conjugate shows early promise against all forms of melanoma
Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
1 May 2014
Immunotherapy in melanoma
Dr Adil I. Daud - University of California San Francisco School of Medicine...
Immunotherapy in melanoma ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014
Role of AORTIC in dealing with rising cancer rates in Africa
North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014
Promising advances in the treatment of lung cancer using MK-3475 as an immune...
Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston...
Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )
1 May 2014
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475
Dr Adil I. Daud - University of California San Francisco School of Medicine...
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475 ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014
New antibody-drug conjugate shows early promise against all forms of melanoma
Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
16 Apr 2014
Biomarker development for ipilimumab and prostate GVAX treatment
Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The...
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014
Toll like receptor 7 agonists for cancer immunotherapy
Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany
Toll like receptor 7 agonists for cancer immunotherapy ( Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany )
25 Mar 2014
Adoptive cell therapy of melanoma with autologous tumour infiltrating...
Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen...
Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes ( Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark )
25 Mar 2014
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Reasons for combining immunotherapy with chemo to enhance anti tumour response
Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014
Dendritic cell vaccination combined with CTLA4 blockade
Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium
Dendritic cell vaccination combined with CTLA4 blockade ( Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium )
25 Mar 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation